BERGAMASCHI, LUCA
 Distribuzione geografica
Continente #
AS - Asia 5.165
NA - Nord America 2.572
EU - Europa 2.426
SA - Sud America 301
AF - Africa 136
OC - Oceania 3
Totale 10.603
Nazione #
US - Stati Uniti d'America 2.466
VN - Vietnam 1.636
SG - Singapore 1.235
IT - Italia 1.193
CN - Cina 1.093
HK - Hong Kong 396
NL - Olanda 229
BR - Brasile 224
IN - India 197
DE - Germania 193
KR - Corea 190
GB - Regno Unito 158
FR - Francia 116
BD - Bangladesh 105
FI - Finlandia 104
JP - Giappone 72
IE - Irlanda 58
CA - Canada 57
CH - Svizzera 50
RU - Federazione Russa 50
SE - Svezia 50
AR - Argentina 38
ES - Italia 38
ID - Indonesia 36
AT - Austria 34
CI - Costa d'Avorio 34
PH - Filippine 33
TH - Thailandia 31
BG - Bulgaria 30
JO - Giordania 28
MX - Messico 28
PL - Polonia 26
TG - Togo 22
TR - Turchia 20
IQ - Iraq 18
ZA - Sudafrica 18
NG - Nigeria 17
BE - Belgio 15
EG - Egitto 14
TW - Taiwan 14
SA - Arabia Saudita 12
HU - Ungheria 11
CO - Colombia 10
UZ - Uzbekistan 10
EC - Ecuador 9
HR - Croazia 8
IR - Iran 8
CL - Cile 7
GR - Grecia 7
SC - Seychelles 7
UA - Ucraina 7
LT - Lituania 6
PK - Pakistan 6
RO - Romania 6
DK - Danimarca 5
DZ - Algeria 5
HN - Honduras 5
PT - Portogallo 5
PY - Paraguay 5
JM - Giamaica 4
MD - Moldavia 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
GH - Ghana 3
GT - Guatemala 3
IL - Israele 3
KE - Kenya 3
MY - Malesia 3
NP - Nepal 3
RS - Serbia 3
SI - Slovenia 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BF - Burkina Faso 2
BY - Bielorussia 2
GE - Georgia 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
OM - Oman 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
CD - Congo 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
ET - Etiopia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LY - Libia 1
NO - Norvegia 1
Totale 10.597
Città #
Singapore 897
Ho Chi Minh City 470
Ashburn 421
Hanoi 405
Hefei 394
Hong Kong 367
San Jose 283
Bologna 250
Chandler 169
Seoul 168
Santa Clara 165
Beijing 122
The Dalles 101
New York 93
Los Angeles 88
Rome 87
Milan 83
Da Nang 79
Boardman 68
Haiphong 68
Dallas 65
Helsinki 63
Tokyo 61
Dublin 58
Lauterbourg 50
Bern 46
Enfield 44
Frankfurt am Main 44
Council Bluffs 42
Munich 42
Dong Ket 40
Hyderabad 39
Bengaluru 36
Abidjan 34
Buffalo 32
Seattle 31
Princeton 30
Southend 30
Turin 30
Sofia 29
Fairfield 28
Amman 27
São Paulo 27
Delhi 26
Nuremberg 26
Hải Dương 25
Redondo Beach 25
Verona 24
Turku 23
Lomé 22
Castel Maggiore 21
Phoenix 21
Chicago 20
Falkenstein 20
Thái Nguyên 20
London 19
Redmond 19
Vienna 19
Amsterdam 18
Biên Hòa 18
Modena 18
Mumbai 18
Shanghai 18
Montreal 17
Warsaw 17
Woodbridge 17
Can Tho 16
Florence 16
Toronto 16
Abeokuta 15
Bắc Ninh 15
Lappeenranta 15
Orem 15
Bến Tre 14
Guangzhou 14
Houston 14
Mexico City 14
Shenzhen 14
Ann Arbor 13
Jakarta 13
Quận Bình Thạnh 13
San Francisco 13
Tân Tiến 13
Vũng Tàu 13
Forlì 12
Wilmington 12
Ha Long 11
Johannesburg 11
Paris 11
Rio de Janeiro 11
Atlanta 10
Baghdad 10
Brussels 10
Budapest 10
Charlotte 10
Des Moines 10
Dhaka 10
Düsseldorf 10
Súria 10
Bari 9
Totale 6.600
Nome #
Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA 438
Body mass index rather than the phenotype impacts precocious ultrasound cardiovascular risk markers in polycystic ovary syndrome 324
Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non–ST-Segment–Elevation Myocardial Infarction 251
Sex-Related Disparities in Cardiac Masses: Clinical Features and Outcomes 248
Diagnostic Accuracy of Cardiac Computed Tomography and 18F-Fluorodeoxyglucose With Positron Emission Tomography in Cardiac Masses 240
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry 215
Classificazione, caratteristiche cliniche e strategie diagnostiche delle masse cardiache 214
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure 209
Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) 197
Performance of Prognostic Scoring Systems in MINOCA: A Comparison among GRACE, TIMI, HEART, and ACEF Scores 196
Cardiac Magnetic Resonance to Predict Cardiac Mass Malignancy: The CMR Mass Score 193
Clinical impact of multimodality assessment of myocardial viability 187
Secondary prevention medical therapy and outcomes in patients with myocardial infarction with non-obstructive coronary artery disease 186
Development and Validation of a Diagnostic Echocardiographic Mass Score in the Approach to Cardiac Masses 184
Ematoma subepicardico: una rara complicanza dell’angioplastica coronarica percutanea 182
Multimodality Imaging in the Diagnostic Work-Up of Patients With Cardiac Masses 175
Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA 175
Genetics and clinical phenotype of Erdheim–Chester disease: A case report of constrictive pericarditis and a systematic review of the literature 172
Comprehensive Non-invasive Versus Invasive Approach to Evaluate Cardiac Allograft Vasculopathy in Heart Transplantation: The CCTA-HTx Study 168
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients 166
Evolution of cardiovascular risk factors and the risk for cardiovascular events in a Caucasian population with polycystic ovary syndrom 162
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 158
The Role of Non-Invasive Multimodality Imaging in Chronic Coronary Syndrome: Anatomical and Functional Pathways 155
Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants 155
Periprocedural myocardial injury and infarction after myocardial revascularization: incidence, clinical features and prognosis 154
Pathological findings at invasive assessment in MINOCA: a systematic review and meta-analysis 151
Reply to SGLT-2 inhibitors: Post-infarction interventional effects 150
Comments on the value of ECG changes in risk stratification of COVID-19 patients Response 146
Clues and pitfalls in the diagnostic approach to cardiac masses: are pseudo-tumours truly benign? 146
The value of ECG changes in risk stratification of COVID-19 patients 145
Prognostic Role of Early Cardiac Magnetic Resonance in Myocardial Infarction With Nonobstructive Coronary Arteries 144
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 143
Ablation of Ventricular and Atrial Arrhythmias in the Era of Cardiac Magnetic Resonance 143
Sex- and age-related differences in outcomes of patients with acute myocardial infarction: MINOCA vs. MIOCA 139
In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study 130
Dieci quesiti in tema di infarto miocardico in assenza di coronaropatia ostruttiva 128
Noninvasive Assessment in Takotsubo Syndrome: A Diagnostic Challenge 128
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry 126
Impact of Admission Hyperglycemia on Heart Failure Events and Mortality in Patients With Takotsubo Syndrome at Long-term Follow-up: Data From HIGH-GLUCOTAKO Investigators 120
Impact of admission hyperglycemia on heart failure events and mortality in patients with takotsubo syndrome at long-term follow-up: Data from high-glucotako investigators. diabetes care 2021;44:2158–2161 120
Characteristics of patients with recurrent acute myocardial infarction after MINOCA 119
Echocardiographic Markers in the Diagnosis of Cardiac Masses 115
Multimodality Non-Invasive Imaging Approach in Acute Coronary Syndrome: Diagnostic and Prognostic Assessment 111
CTA-Derived Pericoronary Fat Attenuation Index Predicts Allograft Rejection and Cardiovascular Events in Heart Transplant Recipients 107
Cardiovascular Disease from Pathophysiology to Risk Estimation: Is Inflammation Estimated through Perivascular Attenuation on Computed Tomography the Key? 106
Imaging approaches in risk stratification of patients with coronary artery disease: a narrative review 105
A textured clinical mosaic involving autoimmune calcific constrictive pericarditis: a case report 104
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry 103
The never-ending challenge of anti-inflammatory therapy after acute myocardial infarction 101
Non-invasive imaging assessment in angina with non-obstructive coronary arteries (ANOCA) 101
Clues and pitfalls in the diagnostic approach to cardiac masses: are pseudo-tumours truly benign? 95
Beyond Coronary Calcium: A New Era in Cardiovascular Risk Assessment 91
Impact of Coronary Microvascular Dysfunction in Takotsubo Syndrome: Cause, Consequence or Both? 90
Identification of Clinical Phenotypes in Type 2 Myocardial Infarction: Insights Into Characteristics, Prognosis, and Management Strategies 90
Myocardial infarction with nonobstructive coronary arteries: From pathophysiology to therapeutic strategies 90
Folic acid and plasma lipids: Interactions and effect of folate supplementation 90
The Spectrum of ECG Abnormalities in a Large Cohort of Cardiac Masses 88
Impact of glucometabolic status on type 4a myocardial infarction in patients with non–ST-segment elevation myocardial infarction: the role of stress hyperglycemia ratio 88
Predictive value of Killip classification in MINOCA patients 87
Malignant Anterior ST-Segment Elevation 87
MINOCA and inflammation: Another piece of the puzzle 85
Myocardial strain of the left ventricle by speckle tracking echocardiography: From physics to clinical practice 80
Acute Response of the Noninfarcted Myocardium and Surrounding Tissue Assessed by T2 Mapping After STEMI 76
Coronary microvascular dysfunction beyond the spectrum of chronic coronary syndromes 76
Diagnostic and Prognostic Role of Cardiac Magnetic Resonance in MINOCA: Systematic Review and Meta-Analysis 76
Left Ventricular Thrombosis in Immune Checkpoint Inhibitor Myocarditis Mimicking ST-Segment Elevation Myocardial Infarction 74
Hallmarks of Left Ventricular Apical Cardiac Mass in a Young Patient 74
Gender and Sex-related differences in Type 2 Myocardial Infarction: the undervalued side of a neglected disease 74
Multimodality Imaging Evaluation to Detect Subtle Right Ventricular Involvement in Patients with Acute Myocarditis and Preserved Left Ventricular Ejection Fraction 69
Prevention of atrial fibrillation with SGLT2 inhibitors across the spectrum of cardiovascular disorders: a meta-analysis of randomized controlled trials 65
Unifying Diagnosis Explaining Multiorgan Clinical Manifestations: The Unique Case of Antiphospholipid Syndrome Leading to MINOCA 64
Cardiac magnetic resonance imaging in myocardial infarction with non-obstructive coronary arteries (MINOCA): current and evolving perspectives 64
The Non-Invasive Diagnosis of Chronic Coronary Syndrome: A Focus on Stress Computed Tomography Perfusion and Stress Cardiac Magnetic Resonance 63
Authors' reply to: 'preventing atrial fibrillation with SGLT2 inhibitors: time, sex, and substrate' by Karakasis et al 60
Diagnostic COncordance in Aortic Regurgitation Severity AssessMent: A ComPARative Study Between Cardiologists With Different Level of Expertise, the COMPARE‐AR Study 51
Clinical outcomes of patients with coronary microvascular dysfunction in absence of obstructive coronary atherosclerosis 49
Bridging the gap: a comprehensive toolkit for assessment of coronary microcirculation in clinical practice 48
Resource utilization and healthcare management of invasive versus non-invasive strategy for cardiac allograft vasculopathy surveillance in heart transplantation 48
Diagnostic approach for coronary microvascular dysfunction in patients with chest pain and no obstructive coronary artery disease 47
The usefulness of speckle tracking echocardiography in identifying subclinical myocardial dysfunction in young adults recovered from mild COVID-19 44
Editorial commentary: Beyond coronary anatomy in acute myocardial infarction: Could stress hyperglycemia ratio be a new prognostic index and therapeutic target? 36
Perspectives in noninvasive imaging for chronic coronary syndromes 36
Reply: MINOCA and CMR: Where Do We Stand? 35
Resting global longitudinal strain and stress echocardiography to detect coronary artery disease burden 34
Contrast Stress Echocardiography Findings in Myocardial Bridging Compared to Normal Coronary Course, With and Without Coronary Artery Disease 34
Hepatic T1 mapping as a novel cardio-hepatic axis imaging biomarker early after ST-elevation myocardial infarction 33
Intelligenza artificiale nella diagnosi e gestione della patologia aortica: applicazioni attuali e prospettive future 32
Targeting subclinical ventricular dysfunction in atrial fibrillation: What can myocardial work add? 31
Prevalence of Pericardial Late Gadolinium Enhancement in Patients After Cardiac Surgery: Clinical and Histological Correlations 27
Arrhythmogenic Risk and Mechanisms of QT-Prolonging Drugs to Treat COVID-19 25
Echocardiography in COVID-19 Pandemic: Clinical Findings and the Importance of Emerging Technology 23
The War for the Best Therapy in Coronary Artery Disease Is Far From Being Won 23
The Role of Cardiovascular Magnetic Resonance in Patients with Mitral Regurgitation 20
Preventing Sudden Cardiac Death in Mitral Valve Prolapse: When Multimodality Imaging Is the Key to Success 18
Impaired left atrial strain as a predictor of bradyarrhythmias and clinical outcomes following TAVI 15
Periprocedural Myocardial Infarction: Do We Need an Updated Definition? 15
Totale 10.855
Categoria #
all - tutte 29.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.202


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202168 0 0 0 0 0 0 0 0 0 0 9 59
2021/2022308 9 4 8 16 26 17 7 20 18 39 78 66
2022/2023746 36 70 12 72 57 41 45 47 106 36 142 82
2023/2024469 29 41 34 25 31 79 11 55 20 71 35 38
2024/20252.405 123 136 133 116 246 122 125 160 95 292 283 574
2025/20266.693 825 608 601 486 601 269 1.138 213 1.202 444 306 0
Totale 10.855